{
    "organizations": [],
    "uuid": "c25213b307e2eb1494891b5c9119fa42a2f1e2b1",
    "author": "",
    "url": "https://www.reuters.com/article/brief-cti-biopharma-to-receive-10-mln-mi/brief-cti-biopharma-to-receive-10-mln-milestone-payment-for-trisenox-idUSASB0C1CS",
    "ord_in_thread": 0,
    "title": "BRIEF-CTI BioPharma to receive $10 mln milestone payment for Trisenox",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 38 AM / Updated 11 minutes ago BRIEF-CTI BioPharma to receive $10 mln milestone payment for Trisenox Reuters Staff \nJan 18 (Reuters) - Cti Biopharma Corp: \n* CTI BIOPHARMA TO RECEIVE $10 MILLION MILESTONE PAYMENT FOR TRISENOX® \n* CTI BIOPHARMA - ‍TO RECEIVE $10 MILLION MILESTONE PAYMENT FROM TEVA PHARMACEUTICAL INDUSTRIES RELATED TO U.S. FDA APPROVAL OF TRISENOX​ Source text for Eikon: Further company coverage:",
    "published": "2018-01-18T08:38:00.000+02:00",
    "crawled": "2018-01-18T08:53:16.007+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "updated",
        "minute",
        "ago",
        "biopharma",
        "receive",
        "mln",
        "milestone",
        "payment",
        "trisenox",
        "reuters",
        "staff",
        "jan",
        "reuters",
        "cti",
        "biopharma",
        "corp",
        "cti",
        "biopharma",
        "receive",
        "million",
        "milestone",
        "payment",
        "cti",
        "biopharma",
        "receive",
        "million",
        "milestone",
        "payment",
        "teva",
        "pharmaceutical",
        "industry",
        "related",
        "fda",
        "approval",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}